The agentic AI market is projected to increase nearly 10 times by 2030.
Zacks Investment Research on MSN
PATH and APP: Two AI stocks worth buying, but one stands stronger
UiPath PATH and AppLovin Corporation APP are two standout names harnessing the power of artificial intelligence to ...
UiPath (PATH) has caught investor attention this week as shares saw a modest uptick, climbing nearly 2% in the latest session. The company's recent price movements have sparked fresh discussion about ...
We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. The second stock on our list of high growth stocks ...
In recent days, UiPath has drawn fresh attention as easing geopolitical tensions and a friendlier backdrop for technology spending have supported renewed interest in AI automation platforms, including ...
The latest price target for UiPath (NYSE:PATH) was reported by Barclays on January 12, 2026. The analyst firm set a price target for $18.00 expecting PATH to rise to within 12 months (a possible 12.99 ...
Software stocks have been pummeled to start 2026.
UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...
UiPath is positioning itself as the bridge connecting humans, systems, and AI. The company has narrowed losses and is approaching profitability. The long-term growth runway is large. If you're looking ...
Zacks Investment Research on MSN
UiPath's platform-led operating leverage in the age of agentic AI
UiPath’s PATH edge in today’s automation race comes down to one thing: how effectively its platform converts AI innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results